Lumibird SA
PAR:LBIRD

Watchlist Manager
Lumibird SA Logo
Lumibird SA
PAR:LBIRD
Watchlist
Price: 7.3 EUR Market Closed
Market Cap: 160.6m EUR
Have any thoughts about
Lumibird SA?
Write Note

Lumibird SA
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lumibird SA
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
Lumibird SA
PAR:LBIRD
Note Receivable
€10.4m
CAGR 3-Years
27%
CAGR 5-Years
15%
CAGR 10-Years
9%
Ses Imagotag SA
PAR:SESL
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Groupe SFPI SA
PAR:SFPI
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gea Grenobloise Electronique Automatisme SA
PAR:GEA
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I2S SA
PAR:ALI2S
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vusiongroup SA
PAR:VU
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Lumibird SA
Glance View

Market Cap
163.7m EUR
Industry
Electrical Equipment

Lumibird SA engages in the design, manufacturing and marketing of lasers. The company is headquartered in Lannion, Bretagne and currently employs 914 full-time employees. The firm offers a range of products, including compact pulsed Nd, double-pulse Nd, tunable laser systems, flash-lamp pumped lasers, diode-pumped solid-state lasers, semiconductor laser modules and intense pulsed light instruments, among others. Lumibird provides lasers to industrial and scientific clients, as well as the medical sector, among others. The firm operates worldwide through the subsidiaries, such as Quantel Medical, which specializes in the development and marketing of diagnostic ocular ultrasound systems and surgical lasers; Quantel USA, which designs and produces fiber lasers, glass laser systems and tunable lasers, and Quantel Derma AT, which focuses on the development, production and sales of the laser technology products in the areas of dermatology and aesthetics.

LBIRD Intrinsic Value
17.05 EUR
Undervaluation 57%
Intrinsic Value
Price

See Also

What is Lumibird SA's Note Receivable?
Note Receivable
10.4m EUR

Based on the financial report for Dec 31, 2023, Lumibird SA's Note Receivable amounts to 10.4m EUR.

What is Lumibird SA's Note Receivable growth rate?
Note Receivable CAGR 10Y
9%

Over the last year, the Note Receivable growth was 23%. The average annual Note Receivable growth rates for Lumibird SA have been 27% over the past three years , 15% over the past five years , and 9% over the past ten years .

Back to Top